{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:38Z","timestamp":1793356838326,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101323","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:17:52Z","timestamp":1791847072000},"page":"101323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of Low-Dose Radiotherapy Combined with Immunotherapy for Drug-Resistant Hepatic Metastasis: a Case Series Analysis"],"prefix":"10.1016","volume":"62","author":[{"given":"Gege","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctro.2026.101323_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5306\/wjco.v15.i4.531","article-title":"Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer","volume":"15","author":"Geng","year":"2024","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101323_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejca.2020.09.037","article-title":"Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review","volume":"141","author":"Bolhuis","year":"2020","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2026.101323_bb0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.amjsurg.2020.02.047","article-title":"Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study","volume":"220","author":"Feng","year":"2020","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.ctro.2026.101323_bb0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15384101.2022.2131163","article-title":"Radiation-induced liver disease: beyond DNA damage","volume":"22","author":"Zhou","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ctro.2026.101323_bb0025","article-title":"Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases","volume":"12","author":"He","year":"2021"},{"issue":"1","key":"10.1016\/j.ctro.2026.101323_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2468-1253(23)00316-3","article-title":"Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial","volume":"9","author":"Liu","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2026.101323_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-025-03766-6","article-title":"Role of radiotherapy on long-term outcomes of patients with small cell lung cancer under different metastasis patterns","volume":"23","author":"Dong","year":"2025","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101323_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-025-01325-5","article-title":"Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy","author":"Gardner","year":"2025","journal-title":"Curr Treat Options in Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101323_bb0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S1470-2045(24)00438-8","article-title":"Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study","volume":"25","author":"Dawson","year":"2024","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101323_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166789","article-title":"Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance","volume":"1869","author":"Wang","year":"2023","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.ctro.2026.101323_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ctro.2026.101323_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1517147","article-title":"Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works","volume":"12","author":"Ren","year":"2025","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.ctro.2026.101323_bb0065","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1186\/s12885-025-15212-7","article-title":"Low-dose radiotherapy combined with chemoimmunotherapy yields superior survival outcomes compared with chemoimmunotherapy alone for patients with small cell lung cancer with liver metastasis: a retrospective study","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ctro.2026.101323_bb0070","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.medj.2024.06.002","article-title":"Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.ctro.2026.101323_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","article-title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial","volume":"23","author":"Schoenfeld","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:06:04Z","timestamp":1793354764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":15,"alternative-id":["S2405630826002181"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101323","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Low-Dose Radiotherapy Combined with Immunotherapy for Drug-Resistant Hepatic Metastasis: a Case Series Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101323"}}